Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Pemetrexed × Other solid neoplasm × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 81 Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Interventions

tazemetostat 1 osunprotafib 1 omburtamab I-131 1 molibresib 1 marizomib 1 Pemetrexed 1 Cisplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00040625 2007-03-15

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Eli Lilly and Company

Approved for marketing

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡